nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—Clidinium—CHRM3—nephrolithiasis	0.0213	0.312	CrCbGaD
Fexofenadine—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0178	0.0461	CcSEcCtD
Fexofenadine—Mepenzolate—CHRM3—nephrolithiasis	0.0171	0.251	CrCbGaD
Fexofenadine—Injury—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0434	CcSEcCtD
Fexofenadine—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0425	CcSEcCtD
Fexofenadine—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0421	CcSEcCtD
Fexofenadine—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0162	0.042	CcSEcCtD
Fexofenadine—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0154	0.0399	CcSEcCtD
Fexofenadine—Diphenidol—CHRM3—nephrolithiasis	0.015	0.22	CrCbGaD
Fexofenadine—Darifenacin—CHRM3—nephrolithiasis	0.0149	0.218	CrCbGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0138	0.0253	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0126	0.0232	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0126	0.0232	CbGpPWpGaD
Fexofenadine—HRH1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0125	0.0228	CbGpPWpGaD
Fexofenadine—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0321	CcSEcCtD
Fexofenadine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0319	CcSEcCtD
Fexofenadine—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0112	0.029	CcSEcCtD
Fexofenadine—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0289	CcSEcCtD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0108	0.0198	CbGpPWpGaD
Fexofenadine—HRH1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0105	0.0192	CbGpPWpGaD
Fexofenadine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00992	0.0256	CcSEcCtD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00986	0.0181	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00986	0.0181	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00957	0.0176	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00957	0.0176	CbGpPWpGaD
Fexofenadine—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00916	0.0237	CcSEcCtD
Fexofenadine—Tension—Hydrochlorothiazide—nephrolithiasis	0.00913	0.0236	CcSEcCtD
Fexofenadine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00903	0.0234	CcSEcCtD
Fexofenadine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.009	0.0233	CcSEcCtD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0089	0.0163	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0089	0.0163	CbGpPWpGaD
Fexofenadine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00876	0.0227	CcSEcCtD
Fexofenadine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00855	0.0221	CcSEcCtD
Fexofenadine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0085	0.022	CcSEcCtD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00847	0.0155	CbGpPWpGaD
Fexofenadine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00822	0.0212	CcSEcCtD
Fexofenadine—Cough—Hydrochlorothiazide—nephrolithiasis	0.00812	0.021	CcSEcCtD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00793	0.0146	CbGpPWpGaD
Fexofenadine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00792	0.0205	CcSEcCtD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00787	0.0144	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00787	0.0144	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00775	0.0142	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00775	0.0142	CbGpPWpGaD
Fexofenadine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00774	0.02	CcSEcCtD
Fexofenadine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00759	0.0196	CcSEcCtD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00747	0.0137	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00747	0.0137	CbGpPWpGaD
Fexofenadine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00741	0.0192	CcSEcCtD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00724	0.0133	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00702	0.0129	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00695	0.0127	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00695	0.0127	CbGpPWpGaD
Fexofenadine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00692	0.0179	CcSEcCtD
Fexofenadine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00687	0.0178	CcSEcCtD
Fexofenadine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00677	0.0175	CcSEcCtD
Fexofenadine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00675	0.0174	CcSEcCtD
Fexofenadine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00668	0.0173	CcSEcCtD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00662	0.0122	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00662	0.0122	CbGpPWpGaD
Fexofenadine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00654	0.0169	CcSEcCtD
Fexofenadine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00649	0.0168	CcSEcCtD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00642	0.0118	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00642	0.0118	CbGpPWpGaD
Fexofenadine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00621	0.016	CcSEcCtD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00619	0.0114	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00615	0.0113	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00615	0.0113	CbGpPWpGaD
Fexofenadine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00603	0.0156	CcSEcCtD
Fexofenadine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.006	0.0155	CcSEcCtD
Fexofenadine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.006	0.0155	CcSEcCtD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00587	0.0108	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00587	0.0108	CbGpPWpGaD
Fexofenadine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00559	0.0145	CcSEcCtD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00548	0.0101	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00546	0.01	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00546	0.01	CbGpPWpGaD
Fexofenadine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00545	0.0141	CcSEcCtD
Fexofenadine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00537	0.0139	CcSEcCtD
Fexofenadine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00519	0.0134	CcSEcCtD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00502	0.00921	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00502	0.00921	CbGpPWpGaD
Fexofenadine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00502	0.013	CcSEcCtD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00501	0.00919	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00501	0.00919	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00486	0.00893	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00486	0.00892	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00486	0.00892	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00483	0.00886	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00483	0.00886	CbGpPWpGaD
Fexofenadine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00483	0.0125	CcSEcCtD
Fexofenadine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00479	0.0124	CcSEcCtD
Fexofenadine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00478	0.0124	CcSEcCtD
Fexofenadine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00476	0.0123	CcSEcCtD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00467	0.00856	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00467	0.00856	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00452	0.0083	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00452	0.0083	CbGpPWpGaD
Fexofenadine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00451	0.0117	CcSEcCtD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0043	0.0079	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0043	0.00789	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00416	0.00763	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00413	0.00758	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00413	0.00758	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00403	0.00739	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00403	0.00739	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00394	0.00722	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00394	0.00722	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00385	0.00706	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0038	0.00697	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0038	0.00697	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00368	0.00675	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00353	0.00648	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00353	0.00648	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00337	0.00618	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00337	0.00618	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00322	0.00591	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00315	0.00577	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00315	0.00577	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00311	0.0057	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00306	0.00562	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00298	0.00547	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00298	0.00547	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00278	0.0051	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00277	0.00509	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00277	0.00509	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00255	0.00468	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00255	0.00468	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00252	0.00462	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00247	0.00454	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00247	0.00454	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0024	0.00441	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00237	0.00435	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00237	0.00435	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GRHPR—nephrolithiasis	0.00218	0.004	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00211	0.00388	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00211	0.00388	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00207	0.00379	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00207	0.00379	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00206	0.00378	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00198	0.00363	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AGXT—nephrolithiasis	0.00194	0.00357	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00184	0.00338	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00181	0.00333	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GRHPR—nephrolithiasis	0.00171	0.00315	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00169	0.0031	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00169	0.00309	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00169	0.00309	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—APRT—nephrolithiasis	0.00165	0.00303	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—SLC26A1—nephrolithiasis	0.00165	0.00303	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—RGS14—nephrolithiasis	0.00165	0.00302	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00157	0.00288	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AGXT—nephrolithiasis	0.00153	0.0028	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GRHPR—nephrolithiasis	0.00147	0.00269	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.00143	0.00263	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AGXT—nephrolithiasis	0.00131	0.0024	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—APRT—nephrolithiasis	0.0013	0.00238	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—SLC26A1—nephrolithiasis	0.0013	0.00238	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00128	0.00234	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00128	0.00234	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00123	0.00225	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00119	0.00218	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00119	0.00218	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AQP1—nephrolithiasis	0.00118	0.00216	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	0.00114	0.0021	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	0.00111	0.00204	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—SLC26A1—nephrolithiasis	0.00111	0.00204	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APRT—nephrolithiasis	0.00111	0.00204	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CHRM3—nephrolithiasis	0.00107	0.00196	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00106	0.00194	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00106	0.00194	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RGS14—nephrolithiasis	0.000973	0.00179	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AQP1—nephrolithiasis	0.000926	0.0017	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000886	0.00163	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000846	0.00155	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CHRM3—nephrolithiasis	0.000837	0.00154	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	0.00081	0.00149	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000805	0.00148	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AQP1—nephrolithiasis	0.000791	0.00145	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PTH—nephrolithiasis	0.000736	0.00135	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000734	0.00135	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CHRM3—nephrolithiasis	0.000716	0.00131	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000691	0.00127	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000657	0.00121	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DGKH—nephrolithiasis	0.000657	0.00121	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000654	0.0012	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000616	0.00113	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APRT—nephrolithiasis	0.000556	0.00102	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000556	0.00102	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000524	0.000962	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000524	0.000962	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	0.000475	0.000872	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTH—nephrolithiasis	0.000435	0.000798	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000396	0.000727	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000373	0.000685	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000358	0.000658	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000338	0.00062	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SPP1—nephrolithiasis	0.000218	0.0004	CbGpPWpGaD
